TY - JOUR
T1 - Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging
AU - Baar, Marjolein P.
AU - Brandt, Renata M.C.
AU - Putavet, Diana A.
AU - Klein, Julian D.D.
AU - Derks, Kasper W.J.
AU - Bourgeois, Benjamin R.M.
AU - Stryeck, Sarah
AU - Rijksen, Yvonne
AU - van Willigenburg, Hester
AU - Feijtel, Danny A.
AU - van der Pluijm, Ingrid
AU - Essers, Jeroen
AU - van Cappellen, Wiggert A.
AU - van IJcken, Wilfred F.
AU - Houtsmuller, Adriaan B.
AU - Pothof, Joris
AU - de Bruin, Ron W.F.
AU - Madl, Tobias
AU - Hoeijmakers, Jan H.J.
AU - Campisi, Judith
AU - de Keizer, Peter L.J.
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2017/3/23
Y1 - 2017/3/23
N2 - The accumulation of irreparable cellular damage restricts healthspan after acute stress or natural aging. Senescent cells are thought to impair tissue function, and their genetic clearance can delay features of aging. Identifying how senescent cells avoid apoptosis allows for the prospective design of anti-senescence compounds to address whether homeostasis can also be restored. Here, we identify FOXO4 as a pivot in senescent cell viability. We designed a FOXO4 peptide that perturbs the FOXO4 interaction with p53. In senescent cells, this selectively causes p53 nuclear exclusion and cell-intrinsic apoptosis. Under conditions where it was well tolerated in vivo, this FOXO4 peptide neutralized doxorubicin-induced chemotoxicity. Moreover, it restored fitness, fur density, and renal function in both fast aging XpdTTD/TTD and naturally aged mice. Thus, therapeutic targeting of senescent cells is feasible under conditions where loss of health has already occurred, and in doing so tissue homeostasis can effectively be restored.
AB - The accumulation of irreparable cellular damage restricts healthspan after acute stress or natural aging. Senescent cells are thought to impair tissue function, and their genetic clearance can delay features of aging. Identifying how senescent cells avoid apoptosis allows for the prospective design of anti-senescence compounds to address whether homeostasis can also be restored. Here, we identify FOXO4 as a pivot in senescent cell viability. We designed a FOXO4 peptide that perturbs the FOXO4 interaction with p53. In senescent cells, this selectively causes p53 nuclear exclusion and cell-intrinsic apoptosis. Under conditions where it was well tolerated in vivo, this FOXO4 peptide neutralized doxorubicin-induced chemotoxicity. Moreover, it restored fitness, fur density, and renal function in both fast aging XpdTTD/TTD and naturally aged mice. Thus, therapeutic targeting of senescent cells is feasible under conditions where loss of health has already occurred, and in doing so tissue homeostasis can effectively be restored.
KW - aging
KW - apoptosis
KW - cell-penetrating peptide
KW - chemotherapy
KW - FOXO4
KW - IL6
KW - LMNB1
KW - Senescence
KW - tissue homeostasis
KW - TP53
UR - http://www.scopus.com/inward/record.url?scp=85016052515&partnerID=8YFLogxK
U2 - 10.1016/j.cell.2017.02.031
DO - 10.1016/j.cell.2017.02.031
M3 - Article
C2 - 28340339
AN - SCOPUS:85016052515
SN - 0092-8674
VL - 169
SP - 132-147.e16
JO - Cell
JF - Cell
IS - 1
ER -